A Randomized Clinical Study of Gefitinib and Pemetrexed as Second Line Therapy 
for Advanced Non-squamous Non-small Cell Lung Cancer

A Randomized Clinical Study of Gefitinib and Pemetrexed as Second Line Therapy 
for Advanced Non-squamous Non-small Cell Lung Cancer

Background and objective Gefitinib and Pemetrexed are drugs used as second-line therapy for advanced non-small cell lung cancer (NSCLC), although studies comparing the two drugs are limited. The aim of this study is to explore the effects, safety, and quality of life (QoL) of Gefitinib and Pemetrexe...

Full description

Bibliographic Details
Main Authors: Hongyu DAI, Ling XU, Chunwei XIA, Wenping CHEN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2013-08-01
Series:Chinese Journal of Lung Cancer
Subjects:
Gefitinib
Pemetrexed
Lung neoplasms
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2013.08.03

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2013.08.03

Similar Items